Proteostasis Therapeutics, Inc.

May 31, 2018

Proteostasis Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

May 08, 2018

Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis

Apr 17, 2018

Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko(TM) Therapy

Apr 04, 2018

Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis

Mar 19, 2018

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock